Theoretical Michaelis-Menten Elimination Model for Propranolol
Overview
Affiliations
A pharmacokinetic model, with Michaelis-Menten elimination, has been developed for drugs and propranolol in particular. The theory is given and the relationship between the area under the theoretical plasma level curve and the absorption rate constant is discussed. This approach allows for an explanation of many of the observed pharmacokinetics of 'Inderal' and particularly 'Inderal' LA; a sustained release preparation of propranolol. In particular, the bioavailability, as measured by area under the curve, is found to be strongly dependent on the absorption half-life in agreement with experimentally observed data.
Flavone acetic acid: a nonlinear pharmacokinetic model.
Gouyette A, Kerr D, Kaye S, Setanoians A, Cassidy J, Bradley C Cancer Chemother Pharmacol. 1988; 22(2):114-9.
PMID: 3409441 DOI: 10.1007/BF00257307.
Propranolol inhalation challenge in relation to histamine response in children with asthma.
Gerritsen J, Koeter G, Vander Weele L, KNOL K Thorax. 1988; 43(6):451-5.
PMID: 2971275 PMC: 461309. DOI: 10.1136/thx.43.6.451.
Clinical significance of pharmacokinetic models of hepatic elimination.
Morgan D, Smallwood R Clin Pharmacokinet. 1990; 18(1):61-76.
PMID: 2178850 DOI: 10.2165/00003088-199018010-00004.
Nonlinear pharmacokinetics: clinical Implications.
Ludden T Clin Pharmacokinet. 1991; 20(6):429-46.
PMID: 2044328 DOI: 10.2165/00003088-199120060-00001.